Act Now, Save Lives: Ensuring Lifesaving Medicines Reach Uganda’s Most Vulnerable

Schistosomiasis remains a major public health threat in Uganda, affecting over 7.4 million people, with 15.7 million at risk. Despite progress in reducing disease prevalence through mass drug administration (MDA), the country now faces an imminent crisis. Due to severe funding shortfalls in 2023, only eight districts have been able to implement the necessary MDA, leaving millions without treatment and exposing vulnerable populations—particularly school-aged children—to preventable illness and long-term complications.

To avert a significant setback, immediate funding of USD 600,000 is urgently needed to distribute 10.3 million Praziquantel (PZQ) tablets before they expire in December 2024. These tablets, generously donated to Uganda, have the potential to treat over 4.5 million individuals, primarily women and children, who are disproportionately affected by schistosomiasis. Without swift action, the expiry of these essential medicines will not only waste valuable resources but also undo years of progress in reducing the burden of this disease.

In collaboration with the Ministry of Health, WHO Uganda, and ESPEN, all stakeholders must act quickly to mobilize the necessary resources. This effort supports the goals of the WHO NTD Roadmap for 2021-2030, aiming to scale up MDA campaigns and strengthen Uganda's fight against neglected tropical diseases. The sustained involvement of donors and partners is critical to close the funding gap and ensure that millions of vulnerable Ugandans receive life-saving treatment.